Ready to Roll! Ten Q3 Biotech Earnings Reports to Watch Next Week
Tag: Takeda
Takeda gets Japanese approval for $62 billion Shire purchase
Takeda gets Japanese approval for $62 billion Shire purchase
Βοστώνη, συνώνυμο του μέλλοντος για τις φαρμακευτικές εταιρείες
Βοστώνη, συνώνυμο του μέλλοντος για τις φαρμακευτικές εταιρείες
Top News from the IASLC 19th World Conference on Lung Cancer 2018
Top News from the IASLC 19th World Conference on Lung Cancer 2018
Takeda’s Alunbrig trounces Pfizer drug in bid for earlier ALK lung cancer use
Takeda's Alunbrig trounces Pfizer drug in bid for earlier ALK lung cancer use
Top Pharma News of the Week
Top Pharma News of the Week
Καρκίνος του Πνεύμονα: Ευρωπαϊκή έγκριση σε νέα θεραπεία από την Takeda
Καρκίνος του Πνεύμονα: Ευρωπαϊκή έγκριση σε νέα θεραπεία από την Takeda
Molecular Templates and Takeda to Take on Multiple Myeloma in Deal Worth up to $632 Million
Molecular Templates and Takeda to Take on Multiple Myeloma in Deal Worth up to $632 Million
Πώληση των ογκολογικών της Shire στη Servier
Πώληση των ογκολογικών της Shire στη Servier
Shire Secures FDA Approval for HAE Drug Lanadelumab
Shire plc snagged approval from the U.S. Food and Drug Administration (FDA) for Takhzyro (lanadelumab-flyo), a prophylaxis to prevent attacks of hereditary angioedema (HAE) in patients 12 years of age and older. Analysts have predicted the drug will achieve blockbuster status, which is a good thing for both Shire and Takeda Pharmaceutical, which struck a deal to acquire Shire earlier this summer. For Shire, … Continue reading Shire Secures FDA Approval for HAE Drug Lanadelumab
Intelligence Pharma 
You must be logged in to post a comment.